|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2531 USD | +4.20% |
|
-.--% | - |
| 06-26 | Neuphoria Confirms Business Combination Talks With Scancell | MT |
| 06-26 | Neuphoria Responds to the Announcement Made by London-Listed Scancell Holdings plc | CI |
Company Valuation: BIONOMICSSADR
Data adjusted to current consolidation scope
| Fiscal Period: June | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 20.36 | 27.18 | - | - |
| Change | - | 33.51% | - | - |
| Enterprise Value (EV) | 20.36 | 27.18 | 27.18 | 27.18 |
| Change | - | 33.51% | 0% | 0% |
| P/E | -30.9x | -0.86x | -1.45x | -1.43x |
| PBR | - | - | - | - |
| PEG | - | -0x | 0x | -1.16x |
| Capitalization / Revenue | 0.86x | - | - | - |
| EV / Revenue | 0x | - | - | - |
| EV / EBITDA | -0x | -1.2x | -1.06x | -0.9x |
| EV / EBIT | -0x | -1.2x | -1.06x | -0.9x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -0.23 | -4.07 | -2.43 | -2.46 |
| Distribution rate | - | - | - | - |
| Net sales 1 | 23.79 | - | - | - |
| EBITDA 1 | -1.717 | -22.66 | -25.74 | -30.08 |
| EBIT 1 | -1.717 | -22.66 | -25.74 | -30.08 |
| Net income 1 | -0.562 | -27 | -24.06 | -28.54 |
| Net Debt | - | - | - | - |
| Reference price 2 | 7.100 | 3.520 | 3.520 | 3.520 |
| Nbr of stocks (in thousands) | 1,880 | 5,405 | - | - |
| Announcement Date | 9/29/25 | - | - | - |
1AUD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 35.1x | 6.14x | 18.98x | 0.94% | 50.35B | ||
| -23.1x | 337.19x | -21.24x | -.--% | 39.21B | ||
| 25.17x | 2.79x | 12.05x | -.--% | 34.52B | ||
| 46.88x | 4.72x | 30.24x | -.--% | 34.6B | ||
| 27.13x | 7.96x | 19.97x | 0.42% | 27.05B | ||
| 31.25x | 5.03x | 22.91x | -.--% | 15.11B | ||
| 24.07x | 2.05x | 9x | 1.11% | 13.85B | ||
| 24.32x | 1.93x | 11.7x | -.--% | 13.18B | ||
| Average | 23.85x | 45.98x | 12.95x | 0.31% | 28.48B | |
| Weighted average by Cap. | 22.88x | 62.03x | 12.07x | 0.32% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- NEUP Stock
- BNOX Stock
- Valuation BIONOMICSSADR
Select your edition
All financial news and data tailored to specific country editions
















